Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challenge.
dc.contributor.author | Julg, Boris. | |
dc.contributor.author | Tartaglia, Lawrence J. | |
dc.contributor.author | Keele, Brandon F. | |
dc.contributor.author | Wagh, Kshitij. | |
dc.contributor.author | Pegu, Amarendra. | |
dc.contributor.author | Sok, Devin. | |
dc.contributor.author | Abbink, Peter. | |
dc.contributor.author | Schmidt, Stephen D. | |
dc.contributor.author | Wang, Keyun. | |
dc.contributor.author | Chen, Xuejun. | |
dc.contributor.author | Joyce, M. Gordon. | |
dc.contributor.author | Georgiev, Ivelin S. | |
dc.contributor.author | Choe, Misook. | |
dc.contributor.author | Kwong, Peter D. | |
dc.contributor.author | Doria-Rose, Nicole A. | |
dc.contributor.author | Le, Khoa. | |
dc.contributor.author | Louder, Mark K. | |
dc.contributor.author | Bailer, Robert T. | |
dc.contributor.author | Moore, Penelope L. | |
dc.contributor.author | Korber, Bette T. M. | |
dc.contributor.author | Seaman, Michael S. | |
dc.contributor.author | Abdool Karim, Salim Safurdeen. | |
dc.contributor.author | Morris, Lynn. | |
dc.contributor.author | Koup, Richard A. | |
dc.contributor.author | Mascola, John R. | |
dc.contributor.author | Burton, Dennis R. | |
dc.contributor.author | Barouch, Dan H. | |
dc.date.accessioned | 2018-03-18T18:47:14Z | |
dc.date.available | 2018-03-18T18:47:14Z | |
dc.date.created | 2017 | |
dc.date.issued | 2017 | |
dc.description | CAPRISA, 2017. | en_US |
dc.description.abstract | Abstract available in pdf. | en_US |
dc.identifier.citation | Julg, B., Tartaglia, L.J., Keele, B.F., Wagh, K., Pegu, A., Sok, D., Abbink, P., Schmidt, S.D., Wang, K., Chen, X., Joyce, M.G., Georgiev, I.S., Choe, M., Kwong, P.D., Doria-Rose, N.A., Le, K., Louder, M.K., Bailer, R.T., Moore, P.L., Korber, B., Seaman, M.S., Abool Karim, S.S., Morris, L., Koup, R.A., Mascola, J.R., Burton, D.R. and Barouch, D.H. 2017. Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challenge. Science Translational Medicine 9(406), eaal1321. | en_US |
dc.identifier.uri | http://hdl.handle.net/10413/15099 | |
dc.language.iso | en | en_US |
dc.publisher | American Association for the Advancement of Science. | en_US |
dc.subject | Broadly neutralizing antibodies. | en_US |
dc.subject | Antibodies. | en_US |
dc.subject | HIV-1. | en_US |
dc.title | Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challenge. | en_US |
dc.type | Peer reviewed journal article | en_US |